Cargando…
Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancer
Autores principales: | Chang, Liang, Gong, Fangchao, Cai, Hongfei, Li, Zhihong, Cui, Youbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713764/ https://www.ncbi.nlm.nih.gov/pubmed/36478910 http://dx.doi.org/10.3892/ol.2022.13595 |
Ejemplares similares
-
miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9
por: Li, Zhihong, et al.
Publicado: (2022) -
Decreased microRNA-132 and its function in human non-small cell lung cancer
por: Liu, Xiyu, et al.
Publicado: (2021) -
miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3
por: Zhao, Zhonghai, et al.
Publicado: (2022) -
Effects of Combined Inhibition of STAT3 and VEGFR2 Pathways on the Radiosensitivity of Non-Small-Cell Lung Cancer Cells [Retraction]
Publicado: (2022) -
Retraction Notice to: Bone Marrow Mesenchymal Stem Cell-Derived Exosomal MicroRNA-126-3p Inhibits Pancreatic Cancer Development by Targeting ADAM9
por: Wu, Dong-Mei, et al.
Publicado: (2022)